The concept of antipsychotic equivalence has been used for decades to compare the dosages and efficacy of antipsychotics, even though it is highly debatable, and with the widespread of atypical antipsychotics also highly criticized, because the antipsychotic effect is not only an isolated result of the blockade of dopamine D2 receptors.
What about you? Do you use the so-called chlorpromazine equivalent (CPZE) in your research? What are the other ways to compare the doses and effectiveness of antipsychotics?